Coronary reserve abnormalities in the infarcted myocardium: Assessment of myocardial viability immediately versus late after reflow by contrast echocardiography

Circulation

Volumn 94, Issue 4, 1996, Pages 748-754

  Villanueva, Flordeliza S ^a   Camarano, Gustavo ^a   Ismail, Suad ^a   Goodman, Norman C ^a   Sklenar, Jiri ^a   Kaul, Sanjiv ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

echocardiography; infarction; myocardium; vasodilation

Indexed keywords

ADENOSINE; DIPYRIDAMOLE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DOG; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REPERFUSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029738425     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.748     Document Type: Article

References (42)

1. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
2. White FC, Sanders M, Bloor CM. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. Am J Cardiol. 1978;42:234-243.
3. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699-1705.
4. Cobb FR, Bache RJ, Rivas F, Greenfield JC. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest. 1976;57:1359-1368.
5. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-1861.
6. Heyndrickx GR, Amano J, Patrick TA, Manders WT, Rogers GG, Rosendorff C, Vatner SF. Effects of coronary artery reperfusion on regional myocardial blood flow and function in conscious baboons. Circulation. 1985;71:1029-1037.
7. Willerson JT, Watson JT, Hutton I, Templeton GH, Fixler DE. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ Res. 1975;36:771-781.
8. Johnson WB, Malone SA, Pantely GA, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation. 1988;78:462-472.
9. Vanhaecke J, Flameng W, Borgers M, Jang I, van de Werf F, De Geest H. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res. 1990;67:1201-1210.
10. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography: implications for determining extent of myocardial salvage. Circulation. 1993;88:2596-2606.
11. Keller MW, Glasheen WP, Kaul S. Albunex®: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr. 1989;2:48-52.
12. Ten Cate FJ, Widimsky P, Cornel JH, Waldstein DJ, Serruys PW, Waaler A. Intracoronary Albunex: its effect on left ventricular hemodynamics. function, and coronary sinus flow in humans. Circulation. 1993;88:2123-2127.
13. Villanueva FS, Glasheen WP, Sklenar J, Jayaweera AR, Kaul S. Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast. Circulation. 1992;85:1557-1564.
14. Jayaweera AR, Matthew TL, Sklenar J, Spotnitz WD, Watson DD, Kaul S. Method for the quantitation of myocardial perfusion during myocardial contrast two-dimensional echocardiography. J Am Soc Echocardiogr. 1990;3:91-98.
15. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation. 1993;88:596-604.
16. Kaul S, Pandian NG, Okada RD, Pohost GM, Weyman AE. Contrast echocardiography in acute myocardial ischemia, I: in-vivo determination of total left ventricular 'area at risk.' J Am Coll Cardiol. 1984;4:1272-1282.
17. Kaul S, Glasheen WP, Ruddy RD, Pandian NG, Weyman AE, Okada RD. The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast echocardiography. Circulation. 1987;75:1249-1260.
18. Kemper AJ, O' Boyle JE, Cohen CA, Taylor A, Parisi AF. Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. Circulation. 1984;70:309-317.
19. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101:593-600.
20. Heymann MA, Payne BD, Hoffman JI, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:55-79.
21. Kaul S, Kelly P, Oliner JD, Glasheen WP, Keller MW, Watson DD. Assessment of regional myocardial blood flow in-vivo with myocardial contrast two-dimensional echocardiography. J Am Coll Cardiol. 1989;13:468-482.
22. Reimer KA, Jennings RB. The 'wavefront phenomenon' of myocardial ischemic cell death, II: transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40:633-644.
23. Olafsson B, Forman MB, Puett DW, Pou A, Gates CU, Friesinger GC, Virmani R. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation. 1987;76:1135-1145.
24. Armiger LC, Gavin JB. Changes in the microvasculature of ischemic and infarcted myocardium. Lab Invest. 1975;33:51-56.
25. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62:945-952.
26. West PN, Connors JP, Clark RE, Weldon CS, Ramsey DL, Roberts R, Sobel BE, Williamson JR. Compromised microvascular integrity in ischemic myocardium. Lab Invest. 1978;38:677-684.
27. Bolli R, Triana F, Jeroudi MO. Prolonged impairment of coronary vasodilation after reversible ischemia. Circ Res. 1990;67:332-343.
28. Ganz W, Watanabe I, Kanamasa K, Yano Y, Han D, Fishbein MC. Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia - half reperfused and half not reperfused. Circulation. 1990;82:1020-1033.
29. Nayler WG, Elz JS. Reperfusion injury: laboratory artifact or clinical dilemma? Circulation. 1986;74:215-221.
30. Forman MB, Virmani R. Pathogenesis and modification of myocardial reperfusion injury. In: Current Topics in Cardiology. New York, NY: Elsevier Science Publishing Co; 1991:349-370.
31. Becker LC, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis. 1987;30:23-44.
32. Belardinelli L, Linden J, Berne R. Cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32:73-91.
33. Skyba DM, Jayaweera AR, Goodman NC, Ismail S, Camarano G, Kaul S. Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast: implications for venous injection. Circulation. 1994;90:1513-1521.
34. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
35. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630-1641.
36. Ellis SE, Wynne J, Braunwald E, Henschkle CI, Sandor T, Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J. 1984;107:9-13.
37. Camarano GP, Ismail S, Goodman NC, Kaul S. Assessment of risk . area during coronary occlusion and infarct size after reperfusion can be determined with myocardial contrast echocardiography using intravenous injections of FS-069, a new contrast agent. Circulation. 1994;90(suppl I):I-68. Abstract.
38. Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol. 1995;26:1340-1347.
39. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration of potential mechanisms. Circulation. 1995;92:2391-2395.
40. Keller MW, Geddes L, Spotnitz WD, Kaul S, Duling BR. Manifestations of reperfusion injury in the microcirculation following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood perfusion: effects of adenosine. Circulation. 1991;84:2485-2494.
41. Ismail S, Spotnitz WD, Jayaweera AR, Goodman NC, Skyba D, Kaul S. Myocardial contrast echocardiography can be used to assess dynamic changes in microvascular function in-vivo. J Am Coll Cardiol. 1995;25:246A. Abstract.
42. Brown KA, O'Meara J, Chambers CE, Plante DA. Ability of dipyridamole thallium-201 imaging 1 to 4 days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol. 1990;65:160-167.